No Detail Found!

Antimicrobial Susceptibility Pattern of Polymyxin B, Tigecycline and Fosfomycin against Carbapenamase Producing Enterobacteriaceae (CPE).

Author(s)
Muhammad Abid Combined Military Hospital Gilgit/National University of Medical Sciences (NUMS) Pakistan
Irfan Ali Mirza Combined Military Hospital Lahore/National University of Medical Sciences (NUMS) Pakistan
Aurangzeb Bhatti Medical Battalion Pano Aqil Pakistan
Shomaila Malik Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan
Aamir Hussain Combined Military Hospital Multan/National University of Medical Sciences (NUMS) Pakistan
Inam Ullah Khan Combined Military Hospital Bahawalpur/National University of Medical Sciences (NUMS) Pakistan
Abstract
Objective: To determine, the susceptibility pattern of carbapenamase producing enterobacteriaceae (CPE) against polymyxinB, tigecycline and fosfomycin. Study Design: Descriptive cross sectional. Place and Duration of Study: The study was carried out in the Department of Microbiology PNS Shifa Karachi, from 26 Sep 2013 to 25 Mar 2014. Material and Methods: All specimens were inoculated on blood and macConkey agar, incubated aerobically at 35ºC - 37ºC for 18 to 24 hours. After identification of gram negative rods by colony morphology, Gram's staining and biochemical reactions, these were screened for Carbapenems resistance with imipenem and meropenem 10 µg discs along with routine first and second line antibiotics by Kirby-Bauer disc diffusion technique according to Clinical Laboratory Standard Institute (CLSI) guide lines. All isolated CPE were saved and then inoculated on Mueller-Hinton agar (MHA). Antimicrobial susceptibility against polymyxin B, Tigecycline and Fosfomycin was done by Kirby-Bauer disc diffusion method using disc polymyxin B 300 units, Tigecycline 15µg and Fosfomycin 200µg. Zone diameters greater than 24 mm were taken as sensitive for Tigecycline 15µg, 16mm for Fosfomycin 200 µg and 12 mm for polymyxin B 300 units. Results: Clinical specimens of 171 patients who fulfilled the inclusion criteria were included in our study. Mean ± SD of age was 42.02 ± 22.367 with C.I (38.65 - 45.40). Out of 171 patients 110 (64%) were male and 61 (36%) were female. In vitro susceptibility results revealed that all the 171 (100%) CPE isolates susceptible to PolymyxinB, while susceptibility against Fosfomycin and Tigecycline was 132 (77%) and 49 (29%) respectively. Conclusion: CPE were found to be 100% susceptible to polymyxinB, while for Fosfomycin and Tigecycline susceptibility was 77% and 29% respectively.
Publication Details
Page(s) 1026-1029
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 67, Issue: 6, Year: 2017

Request the full text from PASTIC

Keywords
PolymyxinB, Tigecycline, Fosfomycin
References
HaraGL,GouldI,EndimianiA,PardoPR,DaikosG,HsuehP,,2013,Detection, treatment, and prevention of carbapenemaseproducing Enterobacteriaceae: Recommendations from an International working group,J Chemother,25,129,40
Papp-WallaceKM,EndimianiA,TaracilaMA,BonomoRA,,2011,Carbapenems: Past, present and future,Antimicrob Agents Chemother,55,4943,60
DayKM,AliS,MirzaIA,SidjabatHE,SilveyA,LanyonCV,,2013,Prevalence and molecular characterization of enterobacteriaceae producing NDM-1 Carbapenems at a military hospital in Pakistan and evaluation of two chromogenic media,Diagn Microbial Infect Dis,75,187,91
LivermoreDM,WarnerM,MushtaqS,DoumithM,ZhangJ,WoodfordN.,,2011,What remains against carbapenem resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline,Int J Antimicrob Agents,37,415,9
,2014,5. Clinical and Laboratory Standards institute (CLSI). Performance standards for antimicrobial susceptibility testing. Twenty-fourth informational supplement,CLSI document M100-S24,,,
,2012,Methods for antimicrobial susceptibility testing,,,,
PasteranF,LuceroC,RapoportM,GuerrieroL,BarreiroI,AlbornozE,,2012,Tigecycline and intravenous fosfomycin zone breakpoints equivalent to the EUCAST MIC criteria for Enterobacteriaceae,J Infect Dev Ctries,6,452,56
BeheraB,MathurP,DasA,KapilA,GuptaB,BhoiS,,2010,Evaluation of susceptibility testing methods for polymyxin,Int J Infect Dis,14,596,601
Van-DuinD,KayeKS,NeunerEA,BonomoRA. Carbapenemresistant,Enterobacteriaceae,,2013,A review of treatment and outcomes,Diagn Microbiol Infect Dis,75,115,20
KumarasamyKK,TolemanMA,WalshTR,BagariaJ,ButtF,Balakrishnan R,,2010,Emergence of a new antibiotic resistance mechanism in India, Pakistan and the UK: A molecular, biological, and epidemiological study,Lancet Infect Dis,10,597,602
NavarroC,Mora-RilloM,Romero-G,Moreno-RamosF,RicoNietoFG,CarrascosoR,-,,,-producing enterobacteriaceae: A major clinical challenge,Pharmacy service, Hospital universitario La PazIDIPAZ,,,
MartinKA,FlorianSB,AgnesAA,SörenG,,2014,Fosfomycin susceptibility in carbapenem resistant enterobacteriaceae from Germany,J Clin Microbiol,52,3135,
0

Citations

0

Downloads

168

Views